Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Equity Average (2016 - 2025)

Standard Biotools (LAB) has disclosed Equity Average for 15 consecutive years, with $412.0 million as the latest value for Q4 2025.

  • Quarterly Equity Average fell 14.27% to $412.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $412.0 million through Dec 2025, down 14.27% year-over-year, with the annual reading at $448.0 million for FY2025, 176.83% up from the prior year.
  • Equity Average for Q4 2025 was $412.0 million at Standard Biotools, roughly flat from $412.1 million in the prior quarter.
  • The five-year high for Equity Average was $543.8 million in Q2 2024, with the low at -$139.9 million in Q4 2023.
  • Average Equity Average over 5 years is $169.3 million, with a median of $110.3 million recorded in 2021.
  • The sharpest move saw Equity Average plummeted 1272.4% in 2023, then surged 616.57% in 2024.
  • Over 5 years, Equity Average stood at $97.0 million in 2021, then crashed by 174.36% to -$72.1 million in 2022, then plummeted by 94.0% to -$139.9 million in 2023, then surged by 443.51% to $480.5 million in 2024, then dropped by 14.27% to $412.0 million in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at $412.0 million, $412.1 million, and $439.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.